Otonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with Tinnitus
OTO-313 demonstrated no clinically meaningful improvement versus placebo for primary and secondary endpoints across all timepoints Company to discontinue development of OTO-313 and implement other measures to extend its cash runway Clinical... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - August 1, 2022 Category: Pharmaceuticals Source Type: clinical trials

Sound Pharma Initiates Enrollment in Pivotal Phase 3 Clinical Trial of SPI-1005 for the Treatment of Hearing Loss and Tinnitus in Meniere ’s Disease
July 28, 2022 -- Sound Pharmaceuticals is pleased to announce that it has enrolled the first patient in its Phase 3 clinical trial involving SPI-1005 for the Treatment of Meniere’s Disease (STOPMD-3). Additionally, this marks the first Phase... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - July 28, 2022 Category: Pharmaceuticals Source Type: clinical trials

Evaluation of Potential Causes of Nap Modulated Tinnitus
Conditions:   Tinnitus;   Hearing Disorders;   Ear Diseases;   Otorhinolaryngologic Diseases Intervention:   Other: Napping Sponsors:   Robin Guillard EIRL;   Fondation Lopez-Loreta;   Service du sommeil de l'hôpital de l'Hôtel-Dieu Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2022 Category: Research Source Type: clinical trials

Effects of CI on Tinnitus and Its Symptoms
Condition:   Tinnitus Intervention:   Device: Cochlear Implant Sponsor:   Chinese PLA General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2022 Category: Research Source Type: clinical trials